Format
Sort by
Items per page

Send to

Choose Destination

Best matches for NAFLD vitamin D:

Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future. Barchetta I et al. Nutrients. (2017)

Vitamin D: a new player in non-alcoholic fatty liver disease? Eliades M et al. World J Gastroenterol. (2015)

NAFLD: Vitamin D-induced autophagy prevents steatosis. Holmes D et al. Nat Rev Endocrinol. (2017)

Search results

Items: 1 to 20 of 215

1.

The Level of Vitamin D in Children and Adolescents with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.

Zhu S, Wang Y, Luo F, Liu J, Xiu L, Qin J, Wang T, Yu N, Wu H, Zou T.

Biomed Res Int. 2019 Jul 14;2019:7643542. doi: 10.1155/2019/7643542. eCollection 2019. Review.

2.

Association Between Index of Nutritional Quality and Nonalcoholic Fatty Liver Disease: The Role of Vitamin D and B Group.

Vahid F, Hekmatdoost A, Mirmajidi S, Doaei S, Rahmani D, Faghfoori Z.

Am J Med Sci. 2019 Jul 1. pii: S0002-9629(19)30258-7. doi: 10.1016/j.amjms.2019.06.008. [Epub ahead of print]

PMID:
31326093
3.

Low vitamin D level was associated with metabolic syndrome and high leptin level in subjects with nonalcoholic fatty liver disease: a community-based study.

Chen LW, Chien CH, Kuo SF, Yu CY, Lin CL, Chien RN.

BMC Gastroenterol. 2019 Jul 16;19(1):126. doi: 10.1186/s12876-019-1040-y.

4.
5.
6.

The Efficacy of Vitamin D Supplementation against Nonalcoholic Fatty Liver Disease: A Meta-Analysis.

Mansour-Ghanaei F, Pourmasoumi M, Hadi A, Ramezani-Jolfaie N, Joukar F.

J Diet Suppl. 2019 Jul 1:1-19. doi: 10.1080/19390211.2019.1624671. [Epub ahead of print]

PMID:
31256692
7.

A narrative review on effects of vitamin D on main risk factors and severity of Non-Alcoholic Fatty Liver Disease.

Sangouni AA, Ghavamzadeh S, Jamalzehi A.

Diabetes Metab Syndr. 2019 May - Jun;13(3):2260-2265. doi: 10.1016/j.dsx.2019.05.013. Epub 2019 May 22. Review.

PMID:
31235166
8.

Study of relationship between total vitamin D level and NAFLD in a sample of Egyptian patients with and without T2DM.

Hosny SS, Ali HM, Mohammed WA, El Ghannam MH.

Diabetes Metab Syndr. 2019 May - Jun;13(3):1769-1771. doi: 10.1016/j.dsx.2019.04.002. Epub 2019 Apr 3. Review.

PMID:
31235092
9.

A New Light on Vitamin D in Obesity: A Novel Association with Trimethylamine-N-Oxide (TMAO).

Barrea L, Muscogiuri G, Annunziata G, Laudisio D, de Alteriis G, Tenore GC, Colao A, Savastano S.

Nutrients. 2019 Jun 10;11(6). pii: E1310. doi: 10.3390/nu11061310.

10.

The Role of Genetic Predisposition, Programing During Fetal Life, Family Conditions, and Post-natal Diet in the Development of Pediatric Fatty Liver Disease.

Mosca A, De Cosmi V, Parazzini F, Raponi M, Alisi A, Agostoni C, Nobili V.

J Pediatr. 2019 Aug;211:72-77.e4. doi: 10.1016/j.jpeds.2019.04.018. Epub 2019 May 23.

PMID:
31128886
11.

Association Between Vitamin D Deficiency and Suspected Nonalcoholic Fatty Liver Disease in an Adolescent Population.

Cho YH, Kim JW, Shim JO, Yang HR, Chang JY, Moon JS, Ko JS.

Pediatr Gastroenterol Hepatol Nutr. 2019 May;22(3):233-241. doi: 10.5223/pghn.2019.22.3.233. Epub 2019 Apr 16.

12.

Low serum vitamin D is independently associated with unexplained elevated ALT only among non-obese men in the general population.

Zelber-Sagi S, Zur R, Thurm T, Goldstein A, Ben-Assuli O, Chodick G, Shibolet O.

Ann Hepatol. 2019 Jul - Aug;18(4):578-584. doi: 10.1016/j.aohep.2019.03.006. Epub 2019 May 7.

13.
14.

Non-alcoholic fatty liver disease and neurological defects.

Moretti R, Caruso P, Gazzin S.

Ann Hepatol. 2019 Jul - Aug;18(4):563-570. doi: 10.1016/j.aohep.2019.04.007. Epub 2019 May 6.

15.

Strong association between serum Vitamin D and Vaspin Levels, AIP, VAI and liver enzymes in NAFLD patients.

Izadi A, Aliasghari F, Gargari BP, Ebrahimi S.

Int J Vitam Nutr Res. 2019 Apr 1:1-8. doi: 10.1024/0300-9831/a000443. [Epub ahead of print]

PMID:
30932788
16.

From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis.

Moore JB.

Proc Nutr Soc. 2019 Aug;78(3):290-304. doi: 10.1017/S0029665119000570. Epub 2019 Mar 29.

17.

Intestinal vitamin D receptor modulates lipid metabolism, adipose tissue inflammation and liver steatosis in obese mice.

Jahn D, Dorbath D, Schilling AK, Gildein L, Meier C, Vuille-Dit-Bille RN, Schmitt J, Kraus D, Fleet JC, Hermanns HM, Geier A.

Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1567-1578. doi: 10.1016/j.bbadis.2019.03.007. Epub 2019 Mar 21.

PMID:
30905785
18.

Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes.

Cipponeri E, Vitturi N, Mariano V, Boscari F, Galasso S, Crepaldi C, Fadini GP, Vigili de Kreutzenberg S, Marescotti MC, Iori E, Cavallin F, Sartori L, Baritussio A, Avogaro A, Bruttomesso D.

J Endocrinol Invest. 2019 Sep;42(9):1099-1107. doi: 10.1007/s40618-019-01031-8. Epub 2019 Mar 7.

PMID:
30847862
19.

Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial.

Ebrahimpour-Koujan S, Sohrabpour AA, Foroughi F, Alvandi E, Esmaillzadeh A.

Trials. 2019 Mar 4;20(1):153. doi: 10.1186/s13063-019-3241-7.

20.

Effect of Vitamin D on Non-Alcoholic Fatty Liver Disease: A Systematic Review of Randomized Controlled Clinical Trials.

Hariri M, Zohdi S.

Int J Prev Med. 2019 Jan 15;10:14. doi: 10.4103/ijpvm.IJPVM_499_17. eCollection 2019. Review.

Supplemental Content

Loading ...
Support Center